| scholarly article | Q13442814 |
| P50 | author | David A. Lewis | Q28112847 |
| Karoly Mirnics | Q42932552 | ||
| P2093 | author name string | Allan R Sampson | |
| Qiang Wu | |||
| Takanori Hashimoto | |||
| H Holly Bazmi | |||
| P2860 | cites work | Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. | Q46842674 |
| Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression | Q48125594 | ||
| Gamma oscillations correlate with working memory load in humans | Q48146164 | ||
| Cortical correlate of the Piper rhythm in humans | Q48323595 | ||
| Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia | Q48414887 | ||
| Induced gamma-band activity during the delay of a visual short-term memory task in humans. | Q48455556 | ||
| Event-related theta oscillations during working memory tasks in patients with schizophrenia and healthy controls | Q48694874 | ||
| Dysfunction of early-stage visual processing in schizophrenia | Q48826515 | ||
| Gating of human theta oscillations by a working memory task. | Q48907870 | ||
| Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia | Q49116761 | ||
| The temporal and spatial origins of cortical interneurons predict their physiological subtype. | Q52033581 | ||
| A network of electrically coupled interneurons drives synchronized inhibitionin neocortex | Q57860893 | ||
| Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia | Q73535859 | ||
| Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study | Q74453180 | ||
| Schizophrenia genes - famine to feast | Q79912937 | ||
| Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression | Q95827751 | ||
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Neural synchrony in schizophrenia: from networks to new treatments | Q24644168 | ||
| A decrease of reelin expression as a putative vulnerability factor in schizophrenia | Q24657918 | ||
| GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons | Q28142612 | ||
| Neuregulin-1 enhances depolarization-induced GABA release | Q28574052 | ||
| Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
| Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study | Q29616193 | ||
| Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors | Q29616809 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks | Q29619466 | ||
| The origin and specification of cortical interneurons | Q29622901 | ||
| Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia | Q30494823 | ||
| Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization | Q32160860 | ||
| Abnormal neural synchrony in schizophrenia. | Q33764355 | ||
| Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. | Q33886021 | ||
| To model a psychiatric disorder in animals: schizophrenia as a reality test | Q33913794 | ||
| Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis | Q33967424 | ||
| Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. | Q34214883 | ||
| Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology | Q34328610 | ||
| Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder | Q34331509 | ||
| Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia | Q34452249 | ||
| Subnucleus-specific loss of neurons in medial thalamus of schizophrenics | Q35203213 | ||
| Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia | Q35544339 | ||
| GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits | Q36790682 | ||
| Working memory dysfunction in schizophrenia | Q40582842 | ||
| Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia | Q43601374 | ||
| Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence | Q44240058 | ||
| Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia | Q44357553 | ||
| Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits | Q44926893 | ||
| Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. | Q45113339 | ||
| Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. | Q45221811 | ||
| Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease | Q45295751 | ||
| Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 | ||
| Dynamics of striate cortical activity in the alert macaque: I. Incidence and stimulus-dependence of gamma-band neuronal oscillations | Q46118991 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 479-489 | |
| P577 | publication date | 2008-02-15 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia | |
| P478 | volume | 165 |
| Q33862117 | -Glial and stem cell expression of murine Fibroblast Growth Factor Receptor 1 in the embryonic and perinatal nervous system |
| Q26749677 | A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation |
| Q43135478 | A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons |
| Q43806919 | A similar but distinctive pattern of impaired cortical excitability in first-episode schizophrenia and ADHD. |
| Q90115882 | Aberrant Cortical Ensembles and Schizophrenia-like Sensory Phenotypes in Setd1a+/- Mice |
| Q36113678 | Abnormal GABAergic function and face processing in schizophrenia: A pharmacologic-fMRI study. |
| Q37584271 | Abnormal GABAergic function and negative affect in schizophrenia. |
| Q36043305 | Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain |
| Q64448884 | Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia |
| Q67496287 | Adolescent social isolation affects parvalbumin expression in the medial prefrontal cortex in the MAM-E17 model of schizophrenia. |
| Q38954270 | Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia. |
| Q50474314 | Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia. |
| Q89218717 | Alterations in cortical interneurons and cognitive function in schizophrenia |
| Q34471254 | Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia |
| Q34384480 | Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia |
| Q34058473 | Alterations of cortical GABA neurons and network oscillations in schizophrenia. |
| Q47310571 | Altered Cortical Ensembles in Mouse Models of Schizophrenia. |
| Q36951303 | Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism |
| Q91014003 | Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders |
| Q47922273 | Altered Global Signal Topography in Schizophrenia |
| Q50540728 | Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia. |
| Q36525031 | Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene |
| Q33977000 | Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits |
| Q26827100 | Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies |
| Q34700955 | Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance |
| Q35633518 | Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia |
| Q34462143 | Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia |
| Q37663262 | Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia |
| Q37418303 | Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects |
| Q37654638 | Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge |
| Q34367499 | Analyzing schizophrenia by DNA microarrays |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q48380933 | Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain |
| Q90646584 | Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis |
| Q35179012 | BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study |
| Q30405706 | Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model |
| Q30473410 | Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia |
| Q34391520 | Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region |
| Q36800477 | Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder |
| Q38941555 | Broader visual orientation tuning in patients with schizophrenia |
| Q104134893 | CRISPR/Cas9-engineered Gad1 elimination in rats leads to complex behavioral changes: implications for schizophrenia |
| Q30497212 | Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. |
| Q36844731 | Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices. |
| Q35593876 | Chemokine receptors and cortical interneuron dysfunction in schizophrenia |
| Q89204110 | Chromosomal Conformations and Epigenomic Regulation in Schizophrenia |
| Q30458099 | Chronic reduction in inhibition reduces receptive field size in mouse auditory cortex |
| Q37544803 | Chronic toxicology of cannabis |
| Q38554843 | Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology |
| Q37139004 | Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia |
| Q36189837 | Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. |
| Q41611408 | Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders. |
| Q91972790 | Cortical Microcircuit Mechanisms of Mismatch Negativity and Its Underlying Subcomponents |
| Q36994831 | Cortical PGC-1α-Dependent Transcripts Are Reduced in Postmortem Tissue From Patients With Schizophrenia |
| Q37973314 | Cortical basket cell dysfunction in schizophrenia |
| Q35740484 | Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features |
| Q35612878 | Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia |
| Q26853430 | Cortical inhibition, excitation, and connectivity in schizophrenia: a review of insights from transcranial magnetic stimulation |
| Q34048651 | Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6 |
| Q35894118 | Cortical opioid markers in schizophrenia and across postnatal development |
| Q48499981 | Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. |
| Q26822851 | Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia |
| Q48695676 | Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms |
| Q45141093 | Deficient GABAergic gliotransmission may cause broader sensory tuning in schizophrenia |
| Q42056544 | Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia |
| Q31113942 | Development of antipsychotic medications with novel mechanisms of action based on computational modeling of hippocampal neuropathology |
| Q35115046 | Developmental Expression Patterns of GABAA Receptor Subunits in Layer 3 and 5 Pyramidal Cells of Monkey Prefrontal Cortex |
| Q34039895 | Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. |
| Q24652714 | Diminished orientation-specific surround suppression of visual processing in schizophrenia |
| Q37515058 | Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. |
| Q36973467 | Dopamine, cognitive function, and gamma oscillations: role of D4 receptors. |
| Q37692058 | Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus. |
| Q35763919 | Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression |
| Q30416848 | Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia |
| Q89582528 | Effect of Immune Activation during Early Gestation or Late Gestation on Inhibitory Markers in Adult Male Rats |
| Q64892777 | Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology. |
| Q34142882 | Elevated gamma-aminobutyric acid levels in chronic schizophrenia |
| Q37672679 | Elevated viral restriction factor levels in cortical blood vessels in schizophrenia |
| Q36831875 | Endocannabinoid metabolism in the prefrontal cortex in schizophrenia |
| Q90047284 | Enriched Environment Reverts Somatostatin Interneuron Loss in MK-801 Model of Schizophrenia |
| Q38079160 | Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors |
| Q34426222 | Epigenetic mechanisms in schizophrenia. |
| Q37955547 | Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? |
| Q33846961 | Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia. |
| Q36483365 | Functional hierarchy underlies preferential connectivity disturbances in schizophrenia |
| Q27013597 | Functional regulation of GABAA receptors in nervous system pathologies |
| Q26864125 | GABA abnormalities in schizophrenia: a methodological review of in vivo studies |
| Q24610466 | GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression |
| Q37929602 | GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia |
| Q24642711 | GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia |
| Q30451228 | GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes |
| Q30479407 | GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders |
| Q34135715 | GABA-based evaluation of neurologic conditions: MR spectroscopy. |
| Q36073289 | GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders |
| Q41370905 | GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies |
| Q41873896 | GABAergic circuit dysfunctions in neurodevelopmental disorders |
| Q35915500 | GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders |
| Q35634284 | Gamma oscillation in schizophrenia. |
| Q34251137 | Gene expression analysis implicates a death receptor pathway in schizophrenia pathology |
| Q39884127 | Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. |
| Q34140405 | Genetic evidence for the association between the early growth response 3 (EGR3) gene and schizophrenia |
| Q30387014 | Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. |
| Q38153036 | High-frequency neural oscillations and visual processing deficits in schizophrenia |
| Q30503608 | Hippocampal interneurons are abnormal in schizophrenia |
| Q37344544 | Immune system disturbances in schizophrenia. |
| Q55080157 | Impaired Binocular Depth Perception in First-Episode Drug-Naive Patients With Schizophrenia. |
| Q64110346 | Impaired Interneuron Development in a Novel Model of Neonatal Brain Injury |
| Q37253341 | Impaired response selection in schizophrenia: evidence from the P3 wave and the lateralized readiness potential |
| Q34424435 | Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia |
| Q33590705 | Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse |
| Q37783378 | Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry |
| Q28077603 | Interneuron Progenitor Transplantation to Treat CNS Dysfunction |
| Q94562279 | Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia |
| Q50902921 | Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs. |
| Q30540206 | Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model |
| Q30499642 | Lamina-Specific Alterations in Cortical GABAA Receptor Subunit Expression in Schizophrenia |
| Q38064198 | Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia |
| Q34421918 | Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268 |
| Q34587796 | Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia |
| Q33603186 | MEG sensor and source measures of visually induced gamma-band oscillations are highly reliable |
| Q33990447 | Mapping Synaptic Pathology within Cerebral Cortical Circuits in Subjects with Schizophrenia |
| Q36554729 | Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia |
| Q27319478 | Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons |
| Q48522858 | Modeling interneuron dysfunction in schizophrenia |
| Q38141822 | Modulating neural plasticity with non-invasive brain stimulation in schizophrenia |
| Q33659830 | Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives |
| Q94560694 | Modulation on Glutamic Pathway of Frontal-Striatum-Thalamus by rs11146020 and rs3813296 Gene Polymorphism in First-Episode Negative Schizophrenia |
| Q34306261 | Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. |
| Q37337567 | Molecular mechanisms and timing of cortical immune activation in schizophrenia. |
| Q37541846 | Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia |
| Q37358661 | Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia? |
| Q33629435 | Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia |
| Q41879463 | NMDA receptor hypofunction phase couples independent γ-oscillations in the rat visual cortex |
| Q36042941 | NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus |
| Q39456064 | NMDAR hypofunction and somatostatin-expressing GABAergic interneurons and receptors: A newly identified correlation and its effects in schizophrenia |
| Q29616196 | Neocortical excitation/inhibition balance in information processing and social dysfunction |
| Q38310750 | Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges |
| Q34151425 | Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders |
| Q34675943 | Neurodevelopment, GABA system dysfunction, and schizophrenia |
| Q36393853 | Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis |
| Q38008890 | Neurons on the move: migration and lamination of cortical interneurons |
| Q34206110 | Neuropathological similarities and differences between schizophrenia and bipolar disorder: a flow cytometric postmortem brain study |
| Q37624654 | Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. |
| Q39004795 | New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy |
| Q36204944 | Nonconscious and conscious color priming in schizophrenia |
| Q30479389 | Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice |
| Q58718220 | Parvalbumin expression and gamma oscillation occurrence increase over time in a neurodevelopmental model of NMDA receptor dysfunction |
| Q42257168 | Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes |
| Q34179419 | Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia |
| Q90141029 | Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies |
| Q46162283 | Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide |
| Q42558886 | Prefrontal cortical GABA modulation of spatial reference and working memory. |
| Q37598224 | Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome |
| Q26829786 | Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders |
| Q30470115 | Prenatal stress: role in psychotic and depressive diseases |
| Q35888156 | Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons |
| Q41646482 | Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. |
| Q36218177 | Reduced contextual effects on visual contrast perception in schizophrenia and bipolar affective disorder |
| Q30447651 | Reduced glutamate decarboxylase 65 protein within primary auditory cortex inhibitory boutons in schizophrenia |
| Q34295745 | Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia |
| Q30519967 | Reduced natural oscillatory frequency of frontal thalamocortical circuits in schizophrenia |
| Q34574517 | Reduced somatostatin in subgenual anterior cingulate cortex in major depression |
| Q36848277 | Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study |
| Q36844622 | Rethinking schizophrenia in the context of normal neurodevelopment |
| Q36501678 | Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia |
| Q35191367 | STEP levels are unchanged in pre-frontal cortex and associative striatum in post-mortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorder |
| Q26766246 | Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior |
| Q34002464 | Schizophrenia as a disorder of disconnectivity |
| Q30484459 | Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies |
| Q34399558 | Selective expression of KCNS3 potassium channel α-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex |
| Q37663640 | Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring |
| Q35171300 | Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia |
| Q35915861 | Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. |
| Q35089413 | Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study |
| Q37116167 | Somatostatin Interneurons Control a Key Component of Mismatch Negativity in Mouse Visual Cortex. |
| Q37850530 | Synaptic changes in the brain of subjects with schizophrenia. |
| Q33516071 | T2 relaxation time abnormalities in bipolar disorder and schizophrenia |
| Q31104394 | The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment |
| Q57170923 | The Perineuronal 'Safety' Net? Perineuronal Net Abnormalities in Neurological Disorders |
| Q34625777 | The chandelier neuron in schizophrenia |
| Q30421323 | The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis |
| Q28081110 | The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia |
| Q34236086 | The molecular pathology of schizophrenia--focus on histone and DNA modifications |
| Q27023087 | The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia |
| Q37369444 | Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects |
| Q26991794 | Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia |
| Q50122927 | Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia |
| Q37633507 | Visual Population Receptive Fields in People with Schizophrenia Have Reduced Inhibitory Surrounds. |
| Q33909771 | Visual masking in schizophrenia: overview and theoretical implications |
| Q37778420 | White matter neuron alterations in schizophrenia and related disorders |
| Q91722360 | White matter neuron biology and neuropathology in schizophrenia |
| Q26999303 | Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia |
| Q33684994 | mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer |
Search more.